Jenscare Scientific Co's quarterly market cap
declined
from Dec. 2022 (HK$27,574.74 Mil) to Jun. 2023 (HK$13,224.19 Mil) and
declined
from Jun. 2023 (HK$13,224.19 Mil) to Dec. 2023 (HK$9,261.11 Mil).
Jenscare Scientific Co's annual market cap
increased
from Dec. 2021 (HK$0.00 Mil) to Dec. 2022 (HK$27,574.74 Mil) but then
declined
from Dec. 2022 (HK$27,574.74 Mil) to Dec. 2023 (HK$9,261.11 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Jenscare Scientific Co's Enterprise Value for Today is HK$510.39 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Jenscare Scientific Co's Market Cap
For the Medical Devices subindustry, Jenscare Scientific Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jenscare Scientific Co's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Jenscare Scientific Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Jenscare Scientific Co's Market Cap falls into.
Jenscare Scientific Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Jenscare Scientific Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jenscare Scientific Co (HKSE:09877) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Jenscare Scientific Co Market Cap Related Terms
Thank you for viewing the detailed overview of Jenscare Scientific Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Jenscare Scientific Co (HKSE:09877) Business Description
Jenscare Scientific Co Ltd is a China-based company mainly engaged in the manufacturing and research and development of medical devices. The company develops interventional products for the treatment of structural heart disease. The company's core products include LuX-Valve and Ken-Valve. LuX-Valve is a transcatheter tricuspid valve replacement system designed for patients with severe tricuspid regurgitation and high surgical risk. Ken-Valve is designed for the treatment of severe aortic regurgitation or combined with aortic stenosis. The company also develops product candidates for the treatment of mitral valve diseases and medical devices for the treatment of heart failure.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:09877 has been successfully added to your